Marshall Wace, LLP Becton Dickinson & CO Transaction History

Marshall Wace, LLP

$90.8 Billion
Q3 2025

A detailed history of Marshall Wace, LLP transactions in Becton Dickinson & CO stock. As of the latest transaction made, Marshall Wace, LLP holds 300 shares of BDX stock, worth $57,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300

Previous 31,876 99.06%

Holding current value

$57,294

Previous $5.49 Million 98.98%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$172.41 - $199.66 $4.93 Million - $5.7 Million	-28,573 Reduced 89.64%	3,303 $618,000
Q2 2025 Aug 13, 2025	BUY	$165.15 - $226.42 $4.13 Million - $5.67 Million	25,022 Added 365.07%	31,876 $5.49 Million
Q1 2025 May 15, 2025	SELL	$222.79 - $249.08 $16.2 Million - $18.1 Million	-72,756 Reduced 91.39%	6,854 $1.57 Million
Q4 2024 Feb 13, 2025	BUY	$220.02 - $243.75 $4.93 Million - $5.47 Million	22,429 Added 39.22%	79,610 $18.1 Million
Q3 2024 Nov 14, 2024	SELL	$221.47 - $242.41 $161 Million - $176 Million	-727,258 Reduced 92.71%	57,181 $13.8 Million

Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $25.9 Million - $28.3 Million	114,867 Added 17.16%	784,439 $183 Million
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $154 Million - $163 Million	658,479 Added 5935.99%	669,572 $166 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $44.6 Million - $51.4 Million	-192,171 Reduced 94.54%	11,093 $2.7 Million
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $253 Million - $282 Million	-992,797 Reduced 83.01%	203,264 $52.5 Million
Q2 2023 Aug 14, 2023	BUY	$238.39 - $265.32 $132 Million - $147 Million	555,090 Added 86.6%	1,196,061 $316 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $75.2 Million - $84.9 Million	327,232 Added 104.3%	640,971 $159 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $68.5 Million - $80.6 Million	313,739 New	313,739 $79.8 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $1.24 Million - $1.45 Million	-5,269 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $2.2 Million - $2.44 Million	-9,010 Reduced 63.1%	5,269 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $3.29 Million - $3.58 Million	14,279 New	14,279 $3.59 Million
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $263,127 - $287,929	-1,131 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $16 Million - $17.7 Million	-68,821 Reduced 98.38%	1,131 $275,000
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $1.98 Million - $2.2 Million	8,933 Added 14.64%	69,952 $17.5 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $13.2 Million - $16.9 Million	61,019 New	61,019 $14.2 Million
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $3.36 Million - $4.02 Million	-15,259 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $2.43 Million - $3.46 Million	-12,396 Reduced 44.82%	15,259 $3.51 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $6.5 Million - $7.34 Million	-27,496 Reduced 49.86%	27,655 $7.52 Million
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $8.94 Million - $9.93 Million	38,782 Added 236.92%	55,151 $14 Million
Q2 2019 Aug 14, 2019	BUY	$217.4 - $246.08 $3.12 Million - $3.54 Million	14,369 Added 718.45%	16,369 $4.13 Million
Q1 2019 May 14, 2019	SELL	$206.05 - $248.17 $5.53 Million - $6.66 Million	-26,847 Reduced 93.07%	2,000 $499,000
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $5.16 Million - $6.5 Million	25,194 Added 689.68%	28,847 $6.5 Million
Q3 2018 Nov 14, 2018	BUY	$233.07 - $256.0 $851,404 - $935,168	3,653 New	3,653 $953,000
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $7.86 Million - $9.19 Million	-38,245 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $7.23 Million - $8.51 Million	38,245	38,245 $8.19 Million

Others Institutions Holding BDX

# of Institutions

1,717

Shares Held

257M

Call Options Held

1.01M

Put Options Held

544K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $54.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Becton Dickinson & CO Transaction History